Naslov: | COVID-19 vaccination hesitancy among people with chronic neurological disorders : a position paper |
---|
Avtorji: | ID Rakuša, Martin (Avtor) ID Öztürk, Serefnur (Avtor) ID Moro, Elena (Avtor) ID Helbok, Raimund (Avtor) ID Bassetti, Claudio (Avtor) ID Beghi, Ettore (Avtor) ID Bereczki, Daniel (Avtor) ID Bodini, Benedetta (Avtor) ID Di Liberto, Giovanni (Avtor) ID Jenkins, Tom (Avtor), et al. |
Datoteke: | Rakusa-2022-COVID-19_vaccination_hesitancy_amo.pdf (1,02 MB) MD5: AEEB9CC074F4F26A358E98FDC412BC39
https://doi.org/10.1111/ene.15368
|
---|
Jezik: | Angleški jezik |
---|
Vrsta gradiva: | Znanstveno delo |
---|
Tipologija: | 1.01 - Izvirni znanstveni članek |
---|
Organizacija: | MF - Medicinska fakulteta
|
---|
Opis: | Background and purpose
Health risks associated with SARS-CoV-2 infection are undisputed. Moreover, the capability of vaccination to prevent symptomatic, severe, and fatal COVID-19 is recognized. There is also early evidence that vaccination can reduce the chance for long COVID-19. Nonetheless, the willingness to get vaccinated and receive booster shots remains subpar among people with neurologic disorders. Vaccine scepticism not only jeopardizes collective efforts to end the COVID-19 pandemic but puts individual lives at risk, as some chronic neurologic diseases are associated with a higher risk for an unfavorable COVID-19 course.
Methods
In this position paper, the NeuroCOVID-19 Task Force of the European Academy of Neurology (EAN) summarizes the current knowledge on the prognosis of COVID-19 among patients with neurologic disease, elucidates potential barriers to vaccination coverage, and formulates strategies to overcome vaccination hesitancy. A survey among the Task Force members on the phenomenon of vaccination hesitancy among people with neurologic disease supports the lines of argumentation.
Results
The study revealed that people with multiple sclerosis and other nervous system autoimmune disorders are most skeptical of SARS-CoV-2 vaccination. The prevailing concerns included the chance of worsening the pre-existing neurological condition, vaccination-related adverse events, and drug interaction.
Conclusions
The EAN NeuroCOVID-19 Task Force reinforces the key role of neurologists as advocates of COVID-19 vaccination. Neurologists need to argue in the interest of their patients about the overwhelming individual and global benefits of COVID-19 vaccination. Moreover, they need to keep on eye on this vulnerable patient group, its concerns, and the emergence of potential safety signals. |
---|
Ključne besede: | advocacy, COVID-19, infectious disease prevention, neurological disorders, SARS-CoV-2, vaccination, vaccine skepticism |
---|
Status publikacije: | Objavljeno |
---|
Verzija publikacije: | Objavljena publikacija |
---|
Poslano v recenzijo: | 12.04.2022 |
---|
Datum sprejetja članka: | 15.04.2022 |
---|
Datum objave: | 23.04.2022 |
---|
Založnik: | Blackwell Science |
---|
Leto izida: | 2022 |
---|
Št. strani: | Str. 2163-2172 |
---|
Številčenje: | Letn. 29, Št. 8 |
---|
PID: | 20.500.12556/DKUM-89282 |
---|
UDK: | 616.8 |
---|
COBISS.SI-ID: | 108168963 |
---|
DOI: | 10.1111/ene.15368 |
---|
ISSN pri članku: | 1468-1331 |
---|
Datum objave v DKUM: | 02.07.2024 |
---|
Število ogledov: | 149 |
---|
Število prenosov: | 9 |
---|
Metapodatki: | |
---|
Področja: | Ostalo
|
---|
:
|
RAKUŠA, Martin, ÖZTÜRK, Serefnur, MORO, Elena, HELBOK, Raimund, BASSETTI, Claudio, BEGHI, Ettore, BERECZKI, Daniel, BODINI, Benedetta, DI LIBERTO, Giovanni in JENKINS, Tom, 2022, COVID-19 vaccination hesitancy among people with chronic neurological disorders : a position paper. European journal of neurology [na spletu]. 2022. Vol. 29, no. Št. 8, p. 2163–2172. [Dostopano 20 januar 2025]. DOI 10.1111/ene.15368. Pridobljeno s: https://dk.um.si/IzpisGradiva.php?lang=slv&id=89282
Kopiraj citat |
---|
| | | Skupna ocena: | (0 glasov) |
---|
Vaša ocena: | Ocenjevanje je dovoljeno samo prijavljenim uporabnikom. |
---|
Objavi na: | |
---|
Iščem podobna dela...
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |